Protective effect of tetrahydroxystilbene glucoside on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Tao, Lizhen ^a   Li, Xiaofeng ^a   Zhang, Lingling ^a   Tian, Jiyu ^a   Li, Xiaobing ^a   Sun, Xin ^a   Li, Xuefen ^a   Jiang, Lin ^a   Zhang, Xiaojun ^b   Chen, Jianzong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ANTIOXIDANT; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TETRAHYDROXYSTILBENE GLUCOSIDE; UNCLASSIFIED DRUG; 2',3',4',5' TETRAHYDROXYSTILBENE 2 O BETA D GLUCOSIDE; 2',3',4',5'-TETRAHYDROXYSTILBENE-2-O-BETA-D-GLUCOSIDE; 3-NITROTYROSINE; DRUG DERIVATIVE; GLUCOSIDE; NEUROPROTECTIVE AGENT; OXIDOPAMINE; STILBENE DERIVATIVE; TYROSINE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL NUCLEUS MEMBRANE; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG STRUCTURE; INTRACELLULAR SIGNALING; NONHUMAN; OXIDATIVE STRESS; PHEOCHROMOCYTOMA CELL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; ANIMAL; CELL NUCLEUS; CELL STRAIN; CELL SURVIVAL; GENE EXPRESSION REGULATION; INTRACELLULAR SPACE; METABOLISM; SIGNAL TRANSDUCTION;

POLYGONUM MULTIFLORUM; RATTUS;

ANIMALS; APOPTOSIS; CELL NUCLEUS; CELL SURVIVAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSIDES; INTRACELLULAR SPACE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; OXIDOPAMINE; PC12 CELLS; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STILBENES; TYROSINE;

EID: 80053613745     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026055     Document Type: Article

References (53)

1. de Lau LM, Breteler MM, (2006) Epidemiology of Parkinson's disease. Lancet Neurol 5: 525-535.
2. Hornykiewicz O, Kish SJ, (1987) Biochemical pathophysiology of Parkinson's disease. Adv Neurol 45: 19-34.
3. Jellinger KA, Kienzl E, Rumpelmaier G, Paulus W, Riederer P, et al. (1993) Iron and ferritin in substantia nigra in Parkinson's disease. Adv Neurol 60: 267-272.
4. Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, et al. (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36: 348-355.
5. Smith MP, Cass WA, (2007) GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease. Neurosci Lett 412: 259-263.
6. Guo S, Bezard E, Zhao B, (2005) Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. Free Radic Biol Med 39: 682-695.
7. Ju MS, Lee P, Kim HG, Lee KY, Hur J, et al. (2010) Protective effects of standardized Thuja orientalis leaves against 6-hydroxyl- dopamine-induced neurotoxicity in SH-SY5Y cells. Toxicol In Vitro 24: 759-765.
8. Tian LL, Wang XJ, Sun YN, Li CR, Xing YL, et al. (2008) Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents 6-hydroxydopamine-induced apoptosis in SH-SY5Y cells. Int J Bio chem Cell Biol 40: 409-422.
9. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, et al. (2001) Molecular pathways involved in the neurotoxicity of 6-OHAD, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65: 135-172.
10. Feng L, Meng H, Wu F, Cheng B, He X, et al. (2008) Olfactory ensheathing cells conditioned medium prevented apoptosis induced by 6-OHDA in PC12 cells through modulation of intrinsic apoptotic pathways. Int J Dev Neurosci 26: 323-329.
11. Gorman AM, Szegezdi E, Quigney DJ, Samali A, (2005) Hsp27 inhibits 6-hydroxydopamine-induced cytochrome-c release and apoptosis in PC12 cells. Biochem Biophys Res Commun 327: 801-810.
12. Schober A, (2004) Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 318: 215-224.
13. Mayo JC, Sainz RM, Antolín I, Rodriguez C, (1999) Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage. Brain Res 818: 221-227.
14. Walkinshaw G, Waters CM, (1994) Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience 63: 975-987.
15. Chan YC, Wang MF, Chang HC, (2003) Polygonum multiflorum extracts improve cognitive performance in senescence accelerated mice. Am J Chin Med 31: 171-179.
16. Li X, Matsumoto K, Murakami Y, Tezuka Y, Wu Y, et al. (2005) Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and manebin mice. Pharmacol Biochem Behav 82: 345-352.
17. Yang X, (1996) Effect of ethanolic extract from root tuber of polygonummultif lorum Thunb on liver and brain monoamine oxidase in senescenceaccelerated mice in vivo. Zhongguo Zhong Yao Za Zhi 21: 48-49.
18. Chen Y, Wang M, Rosen RT, Ho CT, (1999) 2,2-Diphenyl-1-picrylhydrazyl radical-scavenging active components from Polygonum multiflorum Thunb. J Agric Food Chem 47: 2226-2228.
19. Yao S, Li Y, Kong L, (2006) Preparative isolation and purification of chemical constituents from the root of Polygonum multiflorum by high-speed counter-current chromatography. J Chromatogr A 1115: 64-71.
20. Ye S, Tang L, Xu J, Liu Q, Wang J, (2006) Postconditioning's protection of THSG on cardiac ischemia-reperfusion injury and mechanism. J Huazhong Univ Sci Technolog Med Sci 26: 13-16.
21. Zhang YZ, Shen JF, Xu JY, Xiao JH, Wang JL, (2007) Inhibitory effects of 2,3,5,4′-tetrahydroxystilbene-2-O-beta-D-glucoside on experimental inflammation and cyclooxygenase 2 activity. J Asian Nat Prod Res 9: 355-363.
22. Zhang L, Xing Y, Ye CF, Ai HX, Wei HF, et al. (2006) Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside. Behav Brain Res 173: 246-54.
23. Luo HB, Yang JS, Shi XQ, Fu XF, Yang QD, (2009) Tetrahydroxy stilbene glucoside reduces the cognitive impairment and overexpression of amyloid precursor protein induced by aluminum exposure. Neurosci Bull 25: 391-396.
24. Wang T, Gu J, Wu PF, Wang F, Xiong Z, et al. (2009) Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generation. Free Radic Biol Med 47: 229-240.
25. Li X, Li Y, Chen J, Sun J, Li X, et al. (2010) Tetrahydroxystilbene glucoside attenuates MPP+-induced apoptosis in PC12 cells by inhibiting ROS generation and modulating JNK activation. Neurosci Lett 483: 1-5.
26. Qin R, Li X, Li G, Tao L, Li Y, et al. (2011) Protection by tetrahydroxystilbene glucoside against neurotoxicity induced by MPP+: The involvement of PI3K/Akt pathway activation. Toxicol Lett 202: 1-7.
27. Tatton WG, Chalmers-Redman RM, Ju WJ, Mammen M, Carlile GW, et al. (2002) Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn. NGF-differentiated PC12 cells. J Pharmacol Exp Ther 301: 753-764.
28. Liu B, Wang K, Gao HM, Mandavilli B, Wang JY, et al. (2001) Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J Neurochem 77: 182-189.
29. Kojima H, Urano Y, Kikuchi K, Higuchi T, Hirata Y, et al. (1999) Fluorescent Indicators for Imaging Nitric Oxide Production. Angew Chem Int Ed Engl 38: 3209-3212.
30. Bharat S, Cochran BC, Hsu M, Liu J, Ames BN, et al. (2002) Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: implications for Parkinson's disease therapy. Neurotoxicology 23: 479-486.
31. Keller JN, Dimayuga E, Chen Q, Thorpe J, Gee J, et al. (2004) Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int J Biochem Cell Biol 36: 2376-2391.
32. Fujita H, Ogino T, Kobuchi H, Fujiwara T, Yano H, et al. (2006) Cell-permeable cAMP analog suppresses 6-hydroxydopamine- induced apoptosis in PC12 cells through the activation of the Akt pathway. Brain Res 1113: 10-23.
33. Padiglia A, Medda R, Lorrai A, Biggio G, Sanna E, et al. (1997) Modulation of 6-hydroxydopamine oxidation by various proteins. Biochem Pharmacol 53: 1065-108.
34. Yamada K, Umegaki H, Maezawa I, Iguchi A, Kameyama T, et al. (1997) Possible involvement of catalase in the protective effect of interleukin-6 against 6-hydroxydopamine toxicity in PC12 cells. Brain Res Bull 43: 573-577.
35. Nie G, Jin C, Cao Y, Shen S, Zhao B, (2002) Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. Arch Biochem Biophys 397: 84-90.
36. Zhang L, Dawson VL, Dawson TM, (2006) Role of nitric oxide in Parkinson's disease. Pharmacol Ther 109: 33-41.
37. Guix FX, Uribesalgo I, Coma M, Muñoz FJ, (2005) The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 76: 126-152.
38. Duncan AJ, Heales SJ, (2005) Nitric oxide and neurological disorders. Mol Aspects Med 26: 67-96.
39. Dawson TM, Dawson VL, Snyder SH, (1992) A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 32: 297-311.
40. Heales SJ, Bolaños JP, Stewart VC, Brookes PS, Land JM, et al. (1999) Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1410: 215-228.
41. Torreilles F, Salman-Tabcheh S, Guérin M, Torreilles J, (1999) Neurodegenerative disorders: the role of peroxynitrite. Brain Res Brain Res Rev 30: 153-163.
42. Boje KM, (2004) Nitric oxide neurotoxicity in neurodegenerative diseases. Front Biosci 9: 763-776.
43. Gatto EM, Riobó NA, Carreras MC, Schöpfer FJ, Pargament GA, et al. (1999) Circulating plasma factors in Parkinson's disease enhance nitric oxide release of normal human neutrophils. J Neurol Sci 165: 66-70.
44. Chung KK, David KK, (2010) Emerging roles of nitric oxide in neurodegeneration. Nitric Oxide 22: 290-295.
45. Watanabe H, Muramatsu Y, Kurosaki R, Michimata M, Matsubara M, et al. (2004) Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study. Eur Neuropsy- chopharmacol 14: 93-104.
46. Dehmer T, Lindenau J, Haid S, Dichgans J, Schulz JB, (2000) Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J Neurochem 74: 2213-2216.
47. Brown GC, (2010) Nitric oxide and neuronal death. Nitric Oxide 23: 153-165.
48. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA, (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624.
49. Brown GC, (1999) Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1411: 351-369.
50. Castillo MR, Babson JR, (1998) Ca2+-dependent mechanisms of cell injury in cultured cortical neurons. Neuroscience 86: 1133-1144.
51. Godber BL, Doel JJ, Sapkota GP, Blake DR, Stevens CR, et al. (2000) Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. J Biol Chem 275: 7757-7763.
52. Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H, Beckman JS, (1992) Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol 5: 834-842.
53. Althaus JS, Schmidt KR, Fountain ST, Tseng MT, Carroll RT, et al. (2000) LC-MS/MS detection of peroxynitrite-derived 3-nitrotyrosine in rat microvessels. Free Radic Biol Med 29: 1085-1095.